Human papillomavirus type 16 lineage analysis based on E6 region in cervical samples of Iranian women

Berumen, 2001, Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study, J. Natl. Cancer Inst., 93, 1325, 10.1093/jnci/93.17.1325 Bouvard, 2009, A review of human carcinogens—part B: biological agents, Lancet Oncol., 10, 321, 10.1016/S1470-2045(09)70096-8 Burk, 2003, Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix, Cancer Res., 63, 7215 Burk, 2013, Human papillomavirus genome variants, Virology, 445, 232, 10.1016/j.virol.2013.07.018 Cornet, 2012, Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR, J. Virol., 86, 6855, 10.1128/JVI.00483-12 Cornet, 2013, HPV16 genetic variation and the development of cervical cancer worldwide, Br. J. Cancer, 108, 240, 10.1038/bjc.2012.508 Doorbar, 2012, The biology and life-cycle of human papillomaviruses, Vaccine, 30, F55, 10.1016/j.vaccine.2012.06.083 Ellis, 1995, The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer, Nat. Med., 1, 464, 10.1038/nm0595-464 Freitas, 2014, Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions, PLoS One, 9, 10.1371/journal.pone.0100746 Hildesheim, 2001, Human papillomavirus type 16 variants and risk of cervical cancer, J. Natl. Cancer Inst., 93, 315, 10.1093/jnci/93.4.315 Howie, 2009, Papillomavirus E6 proteins, Virology, 384, 324, 10.1016/j.virol.2008.11.017 Huertas-Salgado, 2011, E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature, Virology, 410, 201, 10.1016/j.virol.2010.10.039 International Agency for Research on Cancer. GLOBOCAN, 2012 Jackson, 2016, Functional variants of human papillomavirus type 16 demonstrate host genome integration and transcriptional alterations corresponding to their unique cancer epidemiology, BMC Genomics, 17, 851, 10.1186/s12864-016-3203-3 Jalilvand, 2012, Molecular epidemiology of human herpesvirus 8 variants in Kaposi's sarcoma from Iranian patients, Virus Res., 163, 644, 10.1016/j.virusres.2011.09.027 Jalilvand, 2015, Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: implications for screening and vaccination, J. Med. Virol., 87, 287, 10.1002/jmv.24053 Kammer, 2000, Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity, J Gen Virol, 81, 1975, 10.1099/0022-1317-81-8-1975 Khorasanizadeh, 2013, Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature, Gynecol. Oncol., 128, 277, 10.1016/j.ygyno.2012.11.032 Lizano, 2006, Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population, Gynecol. Oncol., 102, 230, 10.1016/j.ygyno.2005.12.002 Matsumoto, 2000, Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population, Cancer Lett., 156, 159, 10.1016/S0304-3835(00)00457-2 Matsumoto, 2003, Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer, Int. J. Cancer, 106, 919, 10.1002/ijc.11332 McLaughlin-Drubin, 2012, Cancer associated human papillomaviruses, Curr Opin Virol, 2, 459, 10.1016/j.coviro.2012.05.004 Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N. Engl. J. Med., 348, 518, 10.1056/NEJMoa021641 Munoz, 2006, Chapter 1: HPV in the etiology of human cancer, Vaccine, 24, S3/1 Pimenoff, 2017, Transmission between archaic and modern human ancestors during the evolution of the oncogenic human papillomavirus 16, Mol. Biol. Evol., 34, 4, 10.1093/molbev/msw214 Schiffman, 2010, A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia, Cancer Res., 70, 3159, 10.1158/0008-5472.CAN-09-4179 Shang, 2011, Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China, J. Clin. Microbiol., 49, 2656, 10.1128/JCM.02203-10 Sichero, 2007, High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18, Int. J. Cancer, 120, 1763, 10.1002/ijc.22481 Sichero, 2012, Oncogenic potential diverge among human papillomavirus type 16 natural variants, Virology, 432, 127, 10.1016/j.virol.2012.06.011 Smith, 2007, Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update, Int. J. Cancer, 121, 621, 10.1002/ijc.22527 Stephen, 2000, Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China, Int. J. Cancer, 86, 695, 10.1002/(SICI)1097-0215(20000601)86:5<695::AID-IJC15>3.0.CO;2-C Tamura, 2013, MEGA6: molecular evolutionary genetics analysis version 6.0, Mol. Biol. Evol., 30, 2725, 10.1093/molbev/mst197 Togtema, 2015, The human papillomavirus 16 European-T350G E6 variant can immortalize but not transform keratinocytes in the absence of E7, Virology, 485, 274, 10.1016/j.virol.2015.07.025 Villa, 2000, Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia, J Gen. Virol, 81, 2959, 10.1099/0022-1317-81-12-2959 de Villiers, 2004, Classification of papillomaviruses, Virology, 324, 17, 10.1016/j.virol.2004.03.033 Xi, 2006, Human papillomavirus type 16 and 18 variants: race-related distribution and persistence, J. Natl. Cancer Inst., 98, 1045, 10.1093/jnci/djj297 Yamada, 1995, Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments, J. Virol., 69, 7743, 10.1128/JVI.69.12.7743-7753.1995 Yamada, 1997, Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective, J. Virol., 71, 2463, 10.1128/JVI.71.3.2463-2472.1997 Zehbe, 2001, Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes, Int. J. Cancer, 94, 711, 10.1002/ijc.1520 Zehbe, 2003, Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women, Hum. Immunol., 64, 538, 10.1016/S0198-8859(03)00033-8 Zuna, 2009, Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population, Int. J. Cancer, 125, 2609, 10.1002/ijc.24706